Read this brochure for an overview of Palo Alto Networks E-rate eligible products and services, and why K-12 schools and districts choose Palo Alto Networks to protect students across all their digital engagements, from endpoints to the network to the cloud.
Email/phishing attacks are a major concern at healthcare organizations with Austria, Germany, Netherlands, Switzerland, United States, and Nordic countries all listing it as the greatest area of vulnerability
U.S. respondents feel the most prepared to stop cyber-attacks on the network, and least prepared to stop cyber-attacks on unmanaged endpoints
Endpoint and medical devices protection are top of mind with 72.1% stating that deploying effective advance endpoint protection to stop malware like ransomware, 38% are looking for effective exploit kit protection for endpoints and 54% are looking for medical devices protection.
U.S. hospitals report being attacked by cybercriminals (89.5%) nearly two times more frequently than the next nearest country (Germany – 46.0%) over the last 12 months
The U.S. Government’s Continuous Diagnostics and Mitigation (CDM) program “support(s) … government-wide and agency-specific efforts to provide adequate, risk-based, and cost-effective cybersecurity.” The CDM program is designed to roll out in three phases. This white paper describes how the Palo Alto Networks Next-Generation Security Platform, in combination with select technology and delivery partners, supports all three CDM phases and enables agencies to achieve the security objectives of the program.
From pain medication to gene therapy, from clinical trials to regulatory approval, the modern pharmaceutical industry is built on research and information flow. Ensuring both the integrity of data in pharmaceutical operations as well as the protection of the resulting intellectual property are equally important to success. The safety and integrity of plant operations are equally vital to the company’s success. Effectively protecting the IT and OT networks in today’s broad-reaching pharmaceutical networks requires a modernized security approach. The Palo Alto Networks Next-Generation Security Platform is the solution of choice for many modern pharmaceutical companies.
One of the core Amazon® Web Services (AWS®) values is the ability to scale
your applications dynamically as traffic demands dictate. AWS Elastic Load
Balancing (AWS ELB) and AWS Auto Scaling allow you to add new resources,
such as a web server, to your AWS VPC based on observed, increased traffic.
While organizations have gained operational flexibility and lowered data center costs by deploying virtualization solutions, the true promise of a secure, agile, extensible, and flexible private cloud continues to be elusive. One of the key barriers is the ability to deploy security services at the same pace as virtual machine deployments without compromising the level of protection needed. VMware and Palo Alto Networks have partnered to address these challenges.